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ABSTRACT Hospitalisations for severe exacerbations of chronic obstructive pulmonary disease are
associated with significant physical and psychological consequences including an increase in symptom
severity, severe reductions in physical activity, a deleterious effect on skeletal muscle, impaired exercise
tolerance/ability to self-care, decline in quality of life, and increased anxiety and depression. As these
consequences are potentially amenable to exercise training, there is a clear rationale for pulmonary
rehabilitation in the peri/post-exacerbation setting. Although a 2011 Cochrane review was overwhelmingly
positive, subsequent trials have shown less benefit and real-life observational studies have revealed poor
acceptability. Qualitative studies have demonstrated that the patient experience is a determining factor
while the presence of comorbidities may influence referral, adherence and response to pulmonary
rehabilitation. Systematic reviews of less supervised interventions, such as self-management, have shown
limited benefits in the post-exacerbation setting. The recent update of the Cochrane review of peri-
exacerbation pulmonary rehabilitation showed that benefits were associated with the “comprehensive”
nature of the intervention (the number of sessions received, the intensity of exercise training and
education delivered, and the degree of supervision) but implementation is demanding. The challenge is to
develop interventions that are deliverable and acceptable around the time of an acute exacerbation but also
deliver the desired clinical impact.
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Introduction
Severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring hospitalisation place an
enormous burden upon healthcare systems. Up to 75% of COPD costs are accounted for by exacerbations [1],
largely through the costs of hospitalisation [2]. In 2008, there were 822500 hospital stays in the USA with
COPD as the primary diagnosis, with a further 3.2 million stays that included COPD as a secondary or
complicating condition, resulting in aggregate costs of $6.1 billion [3]. In many countries, exacerbations of
COPD are one of the commonest reasons for emergency hospital admission [4]. Furthermore, severe
exacerbations of COPD requiring hospitalisation are associated with high rates of readmission following
discharge, with >20% of patients readmitted within 30 days [5] and a third readmitted within 90 days [6].
Despite the importance of this global healthcare problem, there is a paucity of evidence-based
pharmacological interventions designed to alleviate the consequences of a severe exacerbation of COPD [7, 8].
Pulmonary rehabilitation is defined by the American Thoracic Society and European Respiratory Society
as a “comprehensive intervention based on a thorough patient assessment followed by patient-tailored
therapies that include, but are not limited to, exercise training, education, and behavior change, designed
to improve the physical and psychological condition of people with chronic respiratory disease and to
promote the long-term adherence to health-enhancing behaviors” [9] and is the cornerstone of
nonpharmacological treatment in patients with stable COPD. Over the past decade, there has been a
growing evidence base for the application of pulmonary rehabilitation in the peri-/early post-exacerbation
setting, culminating in a highly positive Cochrane review in 2011 [10], which suggested that pulmonary
rehabilitation in the exacerbation setting may have positive benefits on readmission and survival, as well as
exercise tolerance and health-related quality of life. Based on this Cochrane review, international guidelines
and consensus statements have recommended that patients with COPD should be offered pulmonary
rehabilitation within 4 weeks of hospital discharge [9, 11]. However, recent clinical trials and observational
studies have raised questions not only about patient uptake, adherence and acceptability but also clinical
efficacy [12–15].
This review summarises the physical and psychosocial consequences of a severe exacerbation of COPD,
providing the rationale for pulmonary rehabilitation. The findings from the recent update of the Cochrane
review of peri-exacerbation pulmonary rehabilitation will be described, and we discuss recent studies that
provide insight to some of the barriers to implementation such as comorbidities and patient beliefs.
Finally, the review presents data from recent systematic reviews of self-management interventions (some of
which incorporated exercise-training) as an alternative solution in the peri-exacerbation setting.
Severe exacerbations of COPD: physical and psychosocial consequences
Severe exacerbations of COPD have a devastating effect upon patients. The EXACT-PRO study group
demonstrated that exacerbations are associated with a significant quantitative change in symptom severity
rather than the development of new symptoms [16]. Patient surveys reveal that this change in symptoms
with an exacerbation has a momentous impact upon activities of daily living, with almost 50% reporting a
cessation of all activities or becoming bed/couch bound [17, 18]. This has been corroborated objectively by
observational studies using triaxial accelerometers to quantify daily physical activity in patients
hospitalised with COPD [19]. PITTA et al. [19] demonstrated that at day 2 of hospitalisation, patients spend
only a median 7% of daytime hours on weight-bearing activities (standing and walking), which increased
negligibly to a median 9% by day 7. Even at 1 month following discharge, median time spent in
weight-bearing activities was significantly lower than that observed at the baseline state [19, 20].
The effects of severe physical inactivity in older adults were demonstrated by KORTEBEIN et al. [21] in a
10-day bed rest model. In comparison to the pre-bed rest state, there were large reductions in muscle
protein synthesis, lean mass (particularly of the lower extremities) and leg muscle strength. Similar
findings have been observed in real-life clinical settings: SPRUIT et al. [22] observed a 5% decline in
quadriceps strength between days 3 and 8 in a hospitalised cohort of patients with COPD with only partial
recovery by 90 days from admission. Although physical inactivity is an important phenomenon, severe
exacerbations of COPD are also associated with other factors that may have a deleterious effect upon
skeletal muscle function, including systemic inflammation, oxidative stress, blood gas abnormalities,
corticosteroids and malnutrition [23]. The loss of muscle mass and reduction in muscle function in COPD
is associated with impairment in exercise tolerance and health-related quality of life [24]. Following a
severe exacerbation, there is a well-described decline in field walking test performance [25, 26] and ability
to self-care [27, 28], which are associated with increased risk of readmission [29].
Aside from the physical manifestations, psychosocial consequences are also prominent. The effects of severe
exacerbation on health-related quality in patients with COPD are well described [30]. KON et al. [31]
recently demonstrated that patients with COPD on the day of hospital discharge had higher COPD
Assessment Test (CAT) scores (worse health-related quality of life) than stable hospital outpatients or
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symptomatic patients referred for pulmonary rehabilitation. The mean change in CAT score from hospital
discharge to 3 months after discharge was –3.0 (95% CI –4.4––1.6). MACKAY et al. [32] showed that the
CAT score rose from a mean±SD value of 19.4±6.8 in the stable state to 24.1±7.3 with a community-based
severe exacerbation (p=0.001). The recovery in health-related quality of life to baseline took ∼14 days. In
questionnaire surveys, symptoms of depression, anxiety, panic, resignation and anger are frequently
reported with exacerbation [17]. In a hospitalised COPD cohort, HARRISON et al. [33] recently showed that
significant anxiety and depression were present in >50% and >40% of patients, respectively.
Given the significant physical and psychosocial consequences of exacerbation, and the benefits of
pulmonary rehabilitation in the stable setting [34], there is a clear rationale to assume that pulmonary
rehabilitation may have benefits in the peri-/immediately post-exacerbation setting.
Post-exacerbation rehabilitation: the evidence and the challenges
Although trials of rehabilitation in the acute setting are a relatively recent phenomenon, a Cochrane review
of pulmonary rehabilitation after a COPD exacerbation was published in 2011, which included nine trials
involving 432 participants [10]. The meta-analyses showed that pulmonary rehabilitation reduced the risk
for hospital readmissions substantially (OR 0.22, 95% 0.08–0.58) compared with usual post-exacerbation
management and had a beneficial effect on mortality (OR 0.29, 95% 0.10–0.84), although the mortality
data was heavily based on a single, small trial [10]. Across trials, large and consistent effects of pulmonary
rehabilitation were seen on symptoms, health-related quality of life and exercise capacity. Based on this
systematic review, international guidelines and consensus statements have recommended the provision of
pulmonary rehabilitation after an exacerbation of COPD [9, 11]. The British Thoracic Society guidelines
made a grade A recommendation that COPD patients “should be offered pulmonary rehabilitation at
hospital discharge to commence within 1 month of discharge.” However, they also referred to practical
issues of organising such post-exacerbation programmes.
Since 2011, a number of additional trials have been published and some have shown little benefit from
pulmonary rehabilitation after a COPD exacerbation. In these trials, adherence to rehabilitation was low,
or the exercise programme was short or largely unsupervised [13, 14]. These two studies are the largest
randomised controlled trials in this area but adopted very different approaches; indeed, the authors of the
larger of the two trials were careful not to call their intervention rehabilitation as it did not fulfil
internationally agreed criteria [13]. The studies by EATON et al. [14] and GREENING et al. [13] acknowledged
the deleterious effects of imposed bed rest and commenced the intervention during the inpatient phase.
EATON et al. [14] went on to encourage participants to participate in post-exacerbation pulmonary
rehabilitation, while GREENING et al. [13] adopted a much more “light touch, remotely supervised
programme”. The conflicting results have stimulated discussion about the design and implementation of
pulmonary rehabilitation programmes that would produce patient-important effects [29, 35].
Against this background, the Cochrane review was updated in 2015 with preplanned subgroup analyses of
more versus less “comprehensive” rehabilitation programmes. Rehabilitation programmes were considered
comprehensive if the programme characteristics were in line with the recent statement of the European
Respiratory Society and American Thoracic Society [9], and the British Thoracic Society Guidelines [11]. They
were considered less comprehensive if some components of the programmes were less than the guidance
recommendations (e.g. low overall number of exercise sessions, fewer than two sessions per week, no endurance
training, or no or little supervision). The 2015 Cochrane review included 17 trials with 1104 participants [36].
There was significant heterogeneity in terms of programme composition and results. While the risk of bias and
length of follow-up did not explain heterogeneity, the comprehensiveness of the rehabilitation programmes
appeared to determine their effects. The risk of hospital readmissions was greatly reduced in trials offering a
comprehensive rehabilitation programme (OR 0.10, 95% 0.04–0.28), whereas no effect was observed in the
meta-analysis of trials with a less comprehensive rehabilitation programme (OR 1.10, 95% 0.66–1.82). For
mortality, comprehensiveness of the rehabilitation programmes also explained some of the heterogeneity
(OR 0.28 (95% 0.10–0.84) versus OR 0.99 (95% 0.13–7.57)) although the statistical power was limited. In terms
of health-related quality of life and exercise capacity, the comprehensive programmes showed large effects while
the less comprehensive programmes had smaller effects and substantial heterogeneity across trials.
The less comprehensive programmes were often not less comprehensive by design but encountered greater
challenges in terms of implementation. This can be explained by their ambition to span across settings, i.e.
from the hospital to a rehabilitation centre and, sometimes, to the home setting. Such an approach is
attractive as it reflects real-world settings. Two recent observational studies reflect the challenges with
implementing the results of trials into routine clinical practice. JONES et al. [12] conducted an audit to
prospectively document referral, uptake, adherence and completion rates for early post-hospitalisation
outpatient pulmonary rehabilitation over a 12-month period. Out of 448 hospital discharges for exacerbation
of COPD, only 90 referrals for post-hospitalisation pulmonary rehabilitation were received with only
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43 patients receiving and completing pulmonary rehabilitation (9.6% of all hospital discharges, 15% of
eligible patients) (figure 1). Similarly, HARRISON et al. [33] found acceptance and uptake of pulmonary
rehabilitation following an acute exacerbation was very poor, with only 9% completing the programme. The
challenge lies in finding an acceptable but clinically effective approach. A delayed offer of rehabilitation may
be more feasible given the immediate psychological impact of the disease. The only reported attempt of an
early versus delayed rehabilitation intervention did not report a successful outcome [37] and more recently, a
North American study reported similar recruitment difficulties for trial comparing pulmonary rehabilitation
with a modest physical activity intervention [38].
Thus, an important focus for future research may include implementation science to explore the
integration of comprehensive rehabilitation programmes into the continuum of care of patients with severe
exacerbations of COPD, and the creation of incentives for patients, referrers, providers and payers to
support comprehensive post-exacerbation pulmonary rehabilitation programmes.
The patient experience of an acute exacerbation of COPD
Approximately 45% of individuals with COPD decline a referral to post-acute exacerbation pulmonary
rehabilitation during the inpatient stay, with practical barriers, including transport and medical
appointments, and psychosocial barriers, such as indifference and self-efficacy to exercise, being cited [33].
Recent qualitative research has explored the patient experience of a severe exacerbation of COPD.
Exacerbations are described as having a profound emotional effect [39–42]. Heightened anxiety is expressed
as stemming from breathlessness and a fear of dying: “It is a matter of life and death – you got to get enough
air” [40]. The physical limitations imposed by an exacerbation are viewed as resulting in social isolation,
which leads to feelings of depression: “I am always depressed because of the things I cannot do” [41].
When describing the experience of a hospitalised exacerbation, patients frequently refer to their
interactions with healthcare providers [39, 42]. A subgroup of patients portrayed healthcare providers as
kind and helpful (“They were very helpful and paid close attention – and kind. They would almost see my
needs before I did.” [42]), while others expressed frustration at being dismissed (“They did not take me
seriously. When I am not heard, or unable to express my opinion, I get livid. Anger comes with the
illness.” [42]). Listening has been suggested to increase feelings of control and self-worth [43], which may
be particularly relevant following an exacerbation of COPD, as self-conscious emotions have been found to
be prominent in the narratives of those who decline pulmonary rehabilitation: “I think sometimes the
doctors can be very abrupt with you, as they were this time when I went in…I don’t know whether it’s my
imagination or, I mean doctors are there to treat whoever, you know, and whatever your problem is, I do
understand that, but perhaps my guilt thinking oh perhaps they haven’t got much patience with me
because it’s self-inflicted” [43]. Feelings of shame and guilt associated with culpability for the disease can
mean patients feel unworthy of dedicated care, leading to the refusal of active interventions [43].
Given the prominence of distress following a severe exacerbation of COPD, the timing of referral for
pulmonary rehabilitation requires consideration. During hospitalisation, patients may be more motivated to
FIGURE 1 An audit of the
post-hospitalisation pulmonary
rehabilitation pathway in a
northwest London hospital. Out of
448 hospital discharges following
severe exacerbation of chronic
obstructive pulmonary disease, a
third of patients were not eligible
for pulmonary rehabilitation,
principally due to the presence or
consequences of co-morbidities.
<15% of eligible patients (9% of all
patients) completed a
post-hospitalisation pulmonary
rehabilitation programme. AECOPD:
acute exacerbation of chronic
obstructive pulmonary disease.
Discharged 
with AECOPD
Patient not 
eligible
Patient not 
referred
Patient 
completed
43
47
196
162448
Patient did 
not attend/
complete
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engage in an intervention that may subsequently reduce future admissions. Patients who participated in an
in-hospital exercise intervention found it to be “very helpful, the exercises that were conducted improved my
breathing quite substantially” [44]. These findings are in contrast to a recent large randomised controlled
trial that found in-hospital exercise to be largely ineffective [13]. However, qualitative methodologies may be
more able to characterise the finer-grained issues salient to individuals with COPD, which are not possible to
detect using quantitative assessment. Alternatively, at the time of an exacerbation, breathlessness coupled
with feelings of distress may compromise patients’ ability to absorb the information being provided [39].
Furthermore, the offer of an intervention that inflicts respiratory demands at a time when patients are
acutely short of breath can be perceived as a failure to appreciate the seriousness of the exacerbation [43].
Considering the knowledge gleaned from previous qualitative studies [39–42], it would appear that a
routine assessment of anxiety symptoms following an exacerbation may be necessary with appropriate
psychological support offered. In particular, mindfulness, and acceptance and commitment therapy have
been shown to be effective in reducing levels of anxiety in other chronic disease populations [45, 46].
Secondly, a referral for pulmonary rehabilitation may need to be offered when symptoms have improved
and individuals are more able to attend to the information being provided. Finally, forming a therapeutic
alliance with patients appears to be a key component in enhancing feelings of safety and trust necessary
for engaging in an intervention which provokes breathless symptoms.
The importance of comorbidities at the time of an exacerbation: do these impact on
rehabilitation?
In COPD, comorbidities occur frequently, particularly those related to ageing, smoking and physical inactivity,
such as cardiovascular disease, lung cancer, skeletal muscle dysfunction, metabolic syndrome, depression and
osteoporosis. Comorbidities rarely exist individually: <3% of people with COPD have no comorbidities and
>50% of COPD patients have three or more comorbidities [47]. Recent international guidelines recommend
taking into account comorbidities in the assessment of COPD [48], recognising that many influence disease
progression and prognosis [49]. The way comorbidities are managed in COPD is also important. For example,
COPD patients are less likely to receive a β-blocker at the time of a myocardial infarction, increasing mortality
in this population in comparison to people without COPD [50]. Overall, the presence of comorbidities
increases healthcare utilisation and cost, increases symptoms and morbidity, worsens quality of life, reduces
medication adherence, reduces symptom control, increases medication side-effects, and increases
hospitalisations and mortality. Treating comorbidities has a positive impact on COPD.
How comorbidities influence the diagnosis, severity and management of a COPD exacerbation is
debatable. Where there are common causal pathways for COPD and comorbidities, it is not clear whether
during a COPD exacerbation, the comorbidities automatically exacerbate too. Furthermore, differentiating
an exacerbation of COPD from an exacerbation of a concurrent comorbidity, such as heart failure or a
non-ST elevation myocardial infarction, is not always straightforward. The breathless patient with COPD
presenting as an emergency may be labelled as having an exacerbation when in fact these symptoms could
represent another diagnosis [51]. Indeed, not only are COPD exacerbations misdiagnosed as other things,
exacerbations of other comorbid conditions may be mislabelled as COPD exacerbations. In one study,
atypical presentation and delayed symptom awareness at the time of a ST elevation myocardial infarction
(STEMI) in people with COPD led to a delay in diagnosis of the STEMI, and subsequently a delay in
reperfusion treatment and increased mortality [52]. Misdiagnosis of a COPD exacerbation has a negative
impact on patients and misdiagnosis of comorbidities has negative consequences too.
Several common comorbidities may worsen at the time of an exacerbation, such as osteoporosis, muscle
strength, heart failure, anxiety, depression and diabetes (figure 2). Exacerbations are heterogeneous events,
triggered by viruses, bacteria and environmental exposures. How these triggers affect comorbidities is
likely to differ not only with the different triggers but also with the spectrum of underlying COPD. A
patient with emphysema and heart failure may not have the same decompensation in heart failure with a
virally triggered exacerbation as someone with chronic bronchitis and heart failure exacerbating due to
increased pollution. New comorbidities such as a stroke, myocardial infarction [53] and acute kidney
injury [54] can also occur around the time of an exacerbation. Outside of the acute event, COPD patients
with frequent exacerbations are at risk of developing certain comorbidities including diabetes, heart failure,
myocardial infarction, rheumatological disease, anxiety, depression, asthma and cancer [55]. It is
understandable, therefore, that comorbidities at the time of an exacerbation may prove to be barriers for
onward referral for pulmonary rehabilitation. JONES et al. [12] observed that 162 out of 448 hospitalised
patients with COPD were ineligible for pulmonary rehabilitation, primarily due to the presence of severe
comorbidities such as cardiac instability, terminal illness, severe locomotor or neurological conditions
preventing even limited mobility and cognitive impairment.
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Does pulmonary rehabilitation need to be individualised for people with comorbidities? Physical activity
and regular exercise are recommended and beneficial for individuals with several long-term conditions,
including COPD, cardiovascular disease, musculoskeletal disease, obesity, diabetes and peripheral vascular
disease. Exercise training in the context of pulmonary rehabilitation is extremely important for individuals
with COPD and comorbidities, and has been shown to have a positive outcome on comorbidities [56].
However, pulmonary rehabilitation in its current guise may not be maximally benefiting an individual’s
COPD or their comorbidities. People with anxiety and depression, cardiovascular comorbidities,
osteoporosis, and metabolic disease do not have the same positive outcomes in 6 min walking distance or
dyspnoea score after pulmonary rehabilitation as COPD patients without those comorbidities, suggesting
that there may be scope to modify pulmonary rehabilitation programmes to maximise some of these
outcomes [56]. In one study, people with neurological, musculoskeletal comorbidities and obesity had
better outcomes in a water-based as opposed to a land-based pulmonary rehabilitation programme [57].
What is clear is that comorbidities are extremely common among COPD patients referred for pulmonary
rehabilitation, that the effects of comorbidities on pulmonary rehabilitation outcomes are mixed and that
specific conditions may even impact on programme adherence. Certainly, more could be done and
opportunities gained for increased screening and diagnosis.
Is there a case for self-management support for COPD patients immediately
post-exacerbation?
Given the potential barriers to pulmonary rehabilitation in the acute setting, it has been postulated that
alternative interventions, such as self-management support programmes, may have a role following a
severe exacerbation of COPD. Self-management for patients with COPD is complex and challenging,
requiring patients to manage various facets of their condition, including understanding and taking their
medications appropriately with good inhaler technique, early recognition of exacerbations of symptoms
and early instigation of treatment during an exacerbation, receiving annual influenza vaccinations,
managing their breathlessness to allow them to undertake activities of daily living, bronchial clearance
techniques, taking regular exercise to maintain their lung function and exercise capacity, quitting smoking,
and maintaining a healthy diet [9]. Support from healthcare professionals is less well developed than in
other long-term conditions, with a variety of available tools but no consistent recommended approach [4].
Interventions are usually multicomponent but it remains unclear which are the most important [58]. A
Cochrane review has shown that supported self-management interventions can be effective in reducing
future respiratory admissions and improving quality of life among stable COPD patients [59], although
simple self-management education without support is not effective [60].
FIGURE 2 Comorbidities that may
arise de novo or worsen at the time
of exacerbation.
Fatigue 
Sleep apnoea
Anxiety 
Depression
Stroke
Diabetes
Cachexia
Muscle wasting
Nutritional disorders
Myrocardial infarction
Arrhythmias
Heart failure
Acute kidney injury
Osteoporosis
ERJ Open Res 2015; 1: 00050-2015 | DOI: 10.1183/23120541.00050-2015 6
COPD | W.D-C. MAN ET AL.
A recent systematic review of randomised controlled trials assessed the clinical effectiveness of
interventions to support self-management among patients with COPD who had recently been discharged
from hospital following an acute exacerbation [61]. This review examined interventions that included any
component of self-management support and compared them against usual care, control or other
self-management interventions.
Nine randomised controlled trials were included comprising heterogeneous multicomponent interventions
with varied levels of support, from the very comprehensive, year-long GSuST trial using the Living Well
with COPD programme [62], to much shorter and less supported trials such as a telephone-based
intervention to aid dyspnoea management [63] (figure 3). Trials varied in quality; limited patient
KWOK et al. [64]
Community nurse-based   
  care/self-management
Weekly visits for 4 weeks then 
  monthly + telephone hotline
CASAS et al. [67], 
GARCIA-AYMERICH et al. [68]
Integrated care
Several home visits
6 months
n=157
6 months
n=33
6 months
n=113, 45 
homes
12 months
n=464
3 months
n=66
2 months
n=222
3 months
n=177
3 months
n=60
LEE et al. [66]
Care and self-management 
  support to nursing home
  staff/patients
4× weekly visits, then monthly
WONG et al. [63]
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  self-management
2 contacts
HERMIZ et al. [69]
Home-based care/self-
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2 visits
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Up to 5 visits over 8 weeks + 
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(>6 contacts or unspecified contacts/
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BUCKNALL et al. [62]
Supported self-management
Living well with COPD
Multiple visits
DHEDA et al. [65]
Visits to respiratory 
  nurse/physician ≥4 times
Less supported
(>6 contacts or unspecified contacts/
  <6 weeks duration)
12 months
n=113/155
Usual care
FIGURE 3 Diagram of included randomised controlled trials of supported self-management interventions post-hospital discharge. Reproduced
and modified from [58] with permission from the publisher.
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follow-up and poor reporting were common, particularly among the older trials. No evidence of effect in
favour of self-management support was observed for all-cause mortality (pooled hazard ratio (HR) 1.07,
95% CI 0.74–1.55; I2=0.0% (n=5 trials)) or all-cause hospital admissions (HR 0.88, 95% CI 0.61–1.27;
I2=66.0%). Heterogeneity could not be explained by level of support of the intervention. The most
consistent effects were observed on patients’ quality of life, with an overall improvement of 3.8 points in
the SGRQ score (95% CI 1.29–6.40, I2=14.6%), which is close to the minimum clinically important
difference of 4 points. However, there were substantial and differential losses to follow-up between
intervention and usual care, which could have overestimated the effect. There was also a possible reduction
in anxiety observed in two trials, although the effect observed was small and should be treated with
caution. Overall, although knowledge about COPD improved and patients reported better adherence to
medications and more effective use of inhalers, there was limited evidence of effects on health-related
behaviours, self-efficacy or health outcomes.
These results corroborate another recently published systematic review, which included fewer trials and
used a tighter definition of self-management support [72]. Together, these reviews suggest that there is
insufficient evidence to support self-management interventions following hospital admission for severe
exacerbation of COPD. Furthermore, recent trials and commentaries have indicated that not all patients
are able to self-manage [62, 73]; therefore, future research should focus on careful phenotyping of patients
according to their self-management needs and skills, with a view to more tailored interventions.
Conclusions
It is clear from the evidence that an acute exacerbation of COPD presents a complex scenario to the
healthcare provider and, of course, to the individual (figure 4). The episode provokes a huge disruption to
the individuals’ physical and psychological well-being. The medical management of patients with
exacerbation of COPD is challenged by underlying comorbidities and it is likely that the full impact of the
acute exacerbation on other long-term conditions is not fully appreciated.
There is a clear role for supportive management following severe exacerbation; however, the precise format
of the intervention is less clear. Intuitively, a package of supported self-management would seem the right
approach, instigated immediately upon discharge, but the evidence is lacking. A more structured and
supervised pulmonary rehabilitation programme does have a very strong evidence base, and is consistently
recommended by all national and international societies but – and it is a very large but – once
implemented as a clinical service, it does not seem to be acceptable to a significant proportion of patients,
and perhaps referrers. This presents an interesting challenge for researchers and implementation scientists.
Future work requires a collaborative approach with potential service users to develop an appealing and
effective intervention that can be delivered around the time of an acute exacerbation that will deliver the
desired clinical impact.
FIGURE 4 A white elephant or the
elephant in the room? Pulmonary
rehabilitation following severe
exacerbation of chronic obstructive
pulmonary disease represents a
complex scenario for healthcare
worker and patient.
Alternative approach? Optimal medical 
management
Complex comorbiditiesAcceptability
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Poor referral process
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Physical and 
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